L. Azoulay

First name
L.
Last name
Azoulay
Shapiro, S. B., Yin, H., H. Y. Yu, O., & Azoulay, L. (2024). Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-024-01434-4
View
Simms-Williams, N., Treves, N., Yin, H., Lu, S., Yu, O., Pradhan, R., et al. (2024). Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. Bmj, 385, e078242. http://doi.org/10.1136/bmj-2023-078242
View
Douros, A., Ante, Z., Fallone, C. A., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2024). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population-based nested case-control study. Alzheimers Dement, 20, 1716-1724. http://doi.org/10.1002/alz.13561
View
Shapiro, S. B., Yin, H., H. Y. Yu, O., & Azoulay, L. (2024). Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.16039
View
Pradhan, R., H. Y. Yu, O., Platt, R. W., & Azoulay, L. (2023). Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study. Bmj Open Diabetes Res Care, 11. http://doi.org/10.1136/bmjdrc-2023-003550
View
Douros, A., Ante, Z., Fallone, C. A., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2023). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population-based nested case-control study. Alzheimers Dement. http://doi.org/10.1002/alz.13561
View
Rouette, J., McDonald, E. G., Schuster, T., Matok, I., Brophy, J. M., & Azoulay, L. (2023). Thiazide Diuretics and Risk of Colorectal Cancer: A Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwad171
View
Abrahami, D., D'Andrea, E., Yin, H., Kim, S. C., Paik, J. M., Wexler, D., et al. (2023). Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes Obes Metab. http://doi.org/10.1111/dom.15196
View
Ayele, H. T., Reynier, P., Azoulay, L., Platt, R. W., Cabaussel, J., Benayoun, S., & Filion, K. B. (2023). The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Am J Med. http://doi.org/10.1016/j.amjmed.2023.06.021
View
Doherty, N., Cardwell, C. R., Murchie, P., Hill, C., Azoulay, L., & Hicks, B. (2023). 5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-22-1109
View